Propulsid and Parkinson's disease aggravated - a phase IV clinical study of FDA data

Summary:

Parkinson's disease aggravated is reported as a side effect among people who take Propulsid (cisapride monohydrate), especially for people who are male, 60+ old, also take Ativan, and have Impaired gastric emptying.

The phase IV clinical study analyzes which people have Parkinson's disease aggravated when taking Propulsid. It is created by eHealthMe based on reports of 8,120 people who have side effects when taking Propulsid from the FDA, and is updated regularly.

What is Propulsid?

Propulsid has active ingredients of cisapride monohydrate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 8,130 Propulsid users. Check the latest studies of Propulsid.

What is Parkinson's disease aggravated?

Parkinson's disease aggravated is found to be associated with 1,034 drugs and 442 conditions by eHealthMe. Check the latest studies of Parkinson's disease aggravated.

On Jun, 17, 2026

8,120 people reported to have side effects when taking Propulsid.
Among them, 16 people (0.2%) have Parkinson's disease aggravated.

Could Propulsid cause Parkinson's disease aggravated?

Among these 16 people:

What is the gender of people who have Parkinson's disease aggravated when taking Propulsid? *

female: 43.75 %
male: 56.25 %

What is the age of people who have Parkinson's disease aggravated when taking Propulsid? *

What are other drugs people take besides Propulsid? *

What are other side effects people have besides Parkinson's disease aggravated? *

Movement - Uncontrolled Or Slow: 5 people, 31.25%
Tardive Dyskinesia (a disorder that involves involuntary movements): 5 people, 31.25%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 4 people, 25.00%
Muscle Spasms (muscle contraction): 4 people, 25.00%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 4 people, 25.00%
Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 25.00%
Memory Loss: 4 people, 25.00%
Fatigue (feeling of tiredness): 3 people, 18.75%
Insomnia (sleeplessness): 3 people, 18.75%
Impaired Gastric Emptying: 3 people, 18.75%

What are the existing conditions these people have? *

Impaired Gastric Emptying: 2 people, 12.50%
Nausea (feeling of having an urge to vomit): 1 person, 6.25%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 6.25%
Gastroparesis (delayed emptying of food from the stomach): 1 person, 6.25%
Abdominal Discomfort: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Propulsid and have Parkinson's disease aggravated?

- Check whether Parkinson's disease aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Propulsid:

Propulsid (8,130 reports)

Browse all side effects of Propulsid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Parkinson's disease aggravated:

Parkinson's disease aggravated (1,034 drugs)

Browse all the conditions that are associated with Parkinson's disease aggravated:

Parkinson's disease aggravated (442 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cisapride monohydrate (the active ingredients of Propulsid) and Propulsid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.